238 related articles for article (PubMed ID: 17785319)
1. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis.
Lopez LR; Buckner TR; Hurley BL; Kobayashi K; Matsuura E
Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319
[TBL] [Abstract][Full Text] [Related]
2. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
3. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
6. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
7. Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus.
Zhang C; Li K; Shi B; Wang X; Liu X; Qin W; Han A; Wang J
Clin Chim Acta; 2010 Mar; 411(5-6):395-9. PubMed ID: 20026018
[TBL] [Abstract][Full Text] [Related]
8. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
9. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
Matsuura E; Lopez LR
Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
[TBL] [Abstract][Full Text] [Related]
10. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
Lopez LR; Hurley BL; Simpson DF; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of β₂-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis.
Zhang C; Li X; Niu D; Zi R; Wang C; Han A; Wang X; Li K; Wang J
Clin Chim Acta; 2011 Jul; 412(15-16):1332-6. PubMed ID: 21473861
[TBL] [Abstract][Full Text] [Related]
14. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
Jara LJ; Medina G; Vera-Lastra O; Amigo MC
Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
17. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.
Nakajima K; Nakano T; Tanaka A
Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638
[TBL] [Abstract][Full Text] [Related]
18. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
Kajiwara T; Yasuda T; Matsuura E
J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
[TBL] [Abstract][Full Text] [Related]
19. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
Napoli C
G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
[TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
